HomeVERA • NASDAQ
add
Vera Therapeutics Inc
Previous close
$24.35
Day range
$23.74 - $24.57
Year range
$18.53 - $51.61
Market cap
1.55B USD
Avg Volume
1.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 80.14M | 114.61% |
Net income | -76.53M | -127.04% |
Net profit margin | — | — |
Earnings per share | -1.20 | -93.55% |
EBITDA | -80.02M | -114.38% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 556.83M | 44.86% |
Total assets | 578.53M | 45.62% |
Total liabilities | 110.25M | 58.81% |
Total equity | 468.28M | — |
Shares outstanding | 63.82M | — |
Price to book | 3.32 | — |
Return on assets | -33.71% | — |
Return on capital | -35.30% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -76.53M | -127.04% |
Cash from operations | -54.80M | -121.12% |
Cash from investing | 28.54M | 225.87% |
Cash from financing | 20.28M | 489.85% |
Net change in cash | -5.97M | 86.44% |
Free cash flow | -28.17M | -110.89% |
About
Founded
2016
Headquarters
Website
Employees
192
